share_log

Electrovaya Inc. (OTCMKTS:EFLVF) Short Interest Down 6.9% in January

Defense World ·  Feb 19, 2023 14:41

Electrovaya Inc. (OTCMKTS:EFLVF – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 642,400 shares, a drop of 6.9% from the January 15th total of 689,800 shares. Based on an average daily volume of 210,400 shares, the short-interest ratio is presently 3.1 days.

Electrovaya Stock Down 1.3 %

Shares of OTCMKTS:EFLVF opened at $0.79 on Friday. The firm's 50 day simple moving average is $0.85 and its 200-day simple moving average is $0.80. Electrovaya has a one year low of $0.40 and a one year high of $1.01.

Get Electrovaya alerts:

Wall Street Analysts Forecast Growth

Separately, Alliance Global Partners increased their price target on shares of Electrovaya from C$2.00 to C$2.50 in a report on Wednesday, December 7th.

Electrovaya Company Profile

(Get Rating)

Electrovaya, Inc is a lithium-ion battery technology and manufacturing company. engages in designing, developing, and manufacturing proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications. The firm's businesses include lithium-ion batteries to power MHEVs including forklifts and Automated Guided Vehicles, as well as accessories such as battery chargers to charge the batteries; electromotive power products for electric trucks, electric buses and other transportation applications; industrial products for energy storage; and specialty applications which require complex power solutions, including competencies in building systems for third parties.

Recommended Stories

  • Get a free copy of the StockNews.com research report on Electrovaya (EFLVF)
  • MarketBeat Week in Review – 2/13 – 2/17
  • Deere Stock Raises Outlook and is Ready to Power Higher
  • DraftKings Crowning Achievement: Leverage
  • Tesla Stock Comeback Is Picking Up Steam
  • How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula

Receive News & Ratings for Electrovaya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electrovaya and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment